Royal Philips and Mayo Clinic have announced a collaborative research initiative aimed at advancing MRI technology for cardiac applications. This partnership seeks to integrate artificial intelligence to reduce the complexity and duration of cardiac MRI exams, improving operational efficiency and enhancing patient experiences. With ischemic heart disease being the leading cause of mortality globally, access to high-quality MRI scans is critical for accurate diagnosis and treatment. However, the high cost and time-consuming nature of these exams often limit accessibility. By leveraging AI and Mayo Clinic's proprietary technology, the collaboration hopes to streamline the process, reduce scan times, and enable less experienced radiographers to conduct complex exams, ultimately improving patient outcomes.
In addition to improving MRI scan efficiency, the research will explore the potential of Philips' lower-field-strength MRI solutions, which could expand MRI accessibility for individuals with implants sensitive to high magnetic fields. This innovation is crucial, as an estimated 3.9% of the U.S. population is fitted with metallic orthopedic or cardiac implants, many of whom are currently unable to undergo traditional MRI scans. Philips’ BlueSeal magnet technology, which supports helium-free MRI scanners, exemplifies the company’s commitment to sustainable and affordable cardiovascular MRI solutions.
